Furthermore, miR-21 has also been shown to induce renal fibrosis through multiple pathways including AKT, ERK/MAPK, and it has been shown to target Smad7, which is a negative regulator of TGF-β/Smad3 pathway [38,75]. The gene discussed is AKT1; the disease is renal fibrosis.